| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.16(B) |
| Last
Volume: |
762,316 |
Avg
Vol: |
474,459 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
3 |
6 |
6 |
8 |
| Total Sell Transactions |
5 |
11 |
16 |
28 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-01-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,656 |
7,111 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
214,793 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-01-04 |
4 |
AS |
$243.71 |
$1,243,788 |
D/D |
(5,000) |
15,767 |
|
29% |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-12-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
310 |
11,046 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-11-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,706 |
0 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-11-04 |
4 |
S |
$249.09 |
$1,686,627 |
D/D |
(6,739) |
11,356 |
|
-17% |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-11-04 |
4 |
OE |
$88.05 |
$833,841 |
D/D |
6,739 |
18,095 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-11-03 |
4 |
S |
$236.29 |
$508,015 |
I/I |
(2,150) |
9,821 |
|
-22% |
|
| Llado George |
Director |
• • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
423 |
423 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-11-02 |
4 |
S |
$231.74 |
$5,112,267 |
D/D |
(22,000) |
186,777 |
|
-25% |
|
| Wallman Richard F |
Director |
• • – |
2020-11-02 |
4 |
B |
$233.24 |
$1,411,104 |
I/I |
6,050 |
6,050 |
2.1 |
25% |
|
| Wallman Richard F |
Director |
• • – |
2020-11-02 |
4 |
B |
$232.96 |
$267,902 |
D/D |
1,150 |
31,715 |
2.39 |
25% |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-10-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
180 |
11,971 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People OfficerOffi |
• – – |
2020-10-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,879 |
|
23% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-10-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
208,777 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-10-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
209,777 |
|
- |
|
| Massaro George |
Director |
• • – |
2020-09-14 |
4 |
AS |
$219.27 |
$427,284 |
D/D |
(1,943) |
9,441 |
|
21% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-08-20 |
4 |
S |
$213.51 |
$199,205 |
D/D |
(933) |
22,852 |
|
-16% |
|
| Chubb Stephen D |
Director |
• • – |
2020-08-18 |
4 |
S |
$217.25 |
$217,651 |
D/D |
(1,000) |
37,657 |
|
-14% |
|
| Chubb Stephen D |
Director |
• • – |
2020-08-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
110 |
38,657 |
|
- |
|
| Chubb Stephen D |
Director |
• • – |
2020-08-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
460 |
38,767 |
|
- |
|
| Massaro George |
Director |
• • – |
2020-08-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
11,384 |
|
- |
|
| Kochevar Deborah Turner |
Director |
• • – |
2020-08-07 |
4 |
S |
$216.24 |
$501,467 |
D/D |
(2,319) |
6,728 |
|
-12% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-08-07 |
4 |
S |
$216.42 |
$715,444 |
D/D |
(3,304) |
20,767 |
|
-12% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-08-07 |
4 |
OE |
$144.67 |
$477,990 |
D/D |
3,304 |
24,071 |
|
- |
|
2062 Records found
|
|
Page 17 of 83 |
|
|
1.28 (0.61%) 
